Ramesh Rengan
About
Ramesh Rengan is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation.
According to data from OpenAlex, Ramesh Rengan has authored 157 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Pulmonary and Respiratory Medicine, 56 papers in Radiology, Nuclear Medicine and Imaging and 53 papers in Radiation. Recurrent topics in Ramesh Rengan's work include Lung Cancer Diagnosis and Treatment (67 papers), Advanced Radiotherapy Techniques (52 papers) and Lung Cancer Treatments and Mutations (36 papers). Ramesh Rengan is often cited by papers focused on Lung Cancer Diagnosis and Treatment (67 papers), Advanced Radiotherapy Techniques (52 papers) and Lung Cancer Treatments and Mutations (36 papers). Ramesh Rengan collaborates with scholars based in United States, Netherlands and Canada. Ramesh Rengan's co-authors include Charles B. Simone, Jing Zeng, Jeffrey D. Bradley, George Rodrigues, Stephen M. Hahn, Suresh Senan, Sara Ramella, Marta Moreno, David A. Palma and Lawrence B. Marks and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Ramesh Rengan
151 papers receiving 3.5k citations
Hit Papers
Peers
Ramesh Rengan
William A. Hall United States
Alexander V. Louie Canada
Sara Ramella Italy
Mathias Bressel Australia
Michael MacManus Australia
Eduardo Zubizarreta Austria
Jeffrey A. Bogart United States
Stefanie Corradini Germany
Ute Ganswindt Germany
Steven J. Feigenberg United States
Citations per year, relative to Ramesh Rengan Ramesh Rengan (= 1×)
peers
William A. Hall
Countries citing papers authored by Ramesh Rengan
Since
Specialization
Citations
This map shows the geographic impact of Ramesh Rengan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramesh Rengan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramesh Rengan more than expected).
Fields of papers citing papers by Ramesh Rengan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ramesh Rengan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramesh Rengan. The network helps show where Ramesh Rengan may publish in the future.
Co-authorship network of co-authors of Ramesh Rengan
This figure shows the co-authorship network connecting the top 25 collaborators of Ramesh Rengan. A scholar is included among the top collaborators of Ramesh Rengan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramesh Rengan. Ramesh Rengan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hall, Evan, Raquibul Hannan, Jay J. Liao, et al.. (2024). Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review. Future Oncology. 20(33). 2573–2588.
2.
Thomas, Hannah, Daniel S. Hippe, Parisa Forouzannezhad, et al.. (2022). Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?. Discover Oncology. 13(1). 85–85.
3.
Pietrofesa, Ralph A., Evguenia Arguiri, Constantinos Koumenis, et al.. (2021). Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer. The Journal of Alternative and Complementary Medicine. 27(10). 824–831.
4.
Maity, Amit, Rosemarie Mick, Ramesh Rengan, et al.. (2021). A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes. OncoImmunology. 10(1). 1863631–1863631.
5.
Apisarnthanarax, Smith, Jing Zeng, George E. Laramore, et al.. (2020). Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study. International Journal of Radiation Oncology*Biology*Physics. 108(3). 635–643.
6.
Duan, Chunyan, W. Art Chaovalitwongse, Daniel S. Hippe, et al.. (2020). Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer. Physics in Medicine and Biology. 65(20). 205007–205007.
7.
Huang, Jinfeng, Jianfei Shen, Xiao Li, et al.. (2020). Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Annals of Translational Medicine. 8(7). 482–482.
8.
Bowen, Stephen R., Daniel S. Hippe, W. Art Chaovalitwongse, et al.. (2019). Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging. Clinical Cancer Research. 25(16). 5027–5037.
9.
Thomas, Hannah, Jing Zeng, Paul E. Kinahan, et al.. (2019). Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy. British Journal of Radiology. 92(1103). 20190174–20190174.
10.
Zeng, Jing, et al.. (2018). Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging. International Journal of Radiation Oncology*Biology*Physics. 102(4). 1255–1264.
11.
Schonewolf, Caitlin A., Abigail Doucette, Sunil Singhal, et al.. (2018). Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location. Clinical Lung Cancer. 20(1). e63–e71.
12.
Badiyan, Shahed N., Pranshu Mohindra, Gary Larson, et al.. (2017). Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated with Proton Therapy on the Proton Collaborative Group Prospective Registry Trial. International Journal of Radiation Oncology*Biology*Physics. 99(2). S209–S209.
13.
Remick, Jill, Caitlin A. Schonewolf, Peter Gabriel, et al.. (2017). First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 18(4). 364–371.
14.
Rodrigues, George, Suresh Senan, Cary Oberije, et al.. (2014). Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis. International Journal of Radiation Oncology*Biology*Physics. 90(1). S654–S654.
15.
Rengan, Ramesh, et al.. (2013). Impact of sociodemographic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology Survey. Practical Radiation Oncology. 4(3). e167–e179.
16.
Lin, Lilie L., James B. Stubbs, Ramesh Rengan, et al.. (2012). Radiation Dosimetry and Biodistribution of the Hypoxia Tracer 18 F-EF5 in Oncologic Patients. Cancer Biotherapy and Radiopharmaceuticals. 27(7). 412–419.
17.
Kesarwala, Aparna H., Surbhi Grover, & Ramesh Rengan. (2012). Role of particle beam therapy in a trimodality approach to locally advanced non‐small cell lung cancer. Thoracic Cancer. 4(2). 95–101.
18.
Rengan, Ramesh, Rosemarie Mick, Daniel A. Pryma, et al.. (2012). A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response. Journal of Thoracic Oncology. 7(4). 709–715.
19.
Abdel–Wahab, May, Ramesh Rengan, Bruce Curran, et al.. (2010). Integrating the Healthcare Enterprise in Radiation Oncology Plug and Play—The Future of Radiation Oncology?. International Journal of Radiation Oncology*Biology*Physics. 76(2). 333–336.
20.
Hill‐Kayser, Christine E., Stephen Avery, Cristian Meșină, et al.. (2009). Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques. Journal of Thoracic Oncology. 4(11). 1431–1437.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by William A. Hall Breakdown of academic impact, for papers by Alexander V. Louie Breakdown of academic impact, for papers by Sara Ramella Breakdown of academic impact, for papers by Mathias Bressel Breakdown of academic impact, for papers by Michael MacManus Breakdown of academic impact, for papers by Eduardo Zubizarreta Breakdown of academic impact, for papers by Jeffrey A. Bogart Breakdown of academic impact, for papers by Stefanie Corradini Breakdown of academic impact, for papers by Ute Ganswindt Breakdown of academic impact, for papers by Steven J. Feigenberg